Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Gynecologic Neoplasms
24. February 2026
Search
medline.ch
Gynecologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 16241
Articles 1 - 20 / 324814
Adebrelimab in combination with dalpiciclib and endocrine therapy as neoadjuvant treatment for HR+/HER2- early breast cancer: an exploratory study.
Int J Surg
Xiao M, Ren H, Han X, Huang F, Zhang CS, Lei B, Wang J, Liu T.
PMID: 41729711 [PubMed - as supplied by publisher]
[Breast cancer: an example of changing practices that take age-related factors into account. About the ASTER 70s study].
Rev Prat
Brain É, Rollot-Trad F, Rochette de Lempdes G, Bringuier M, Roque T, Henriques J, Vernerey D.
PMID: 41729638 [PubMed - indexed for MEDLINE]
Examining the Representation of Minority Race and Ethnicity Groups in Breast Cancer Clinical Trials in the USA Published 2012-2022.
Ann Surg Oncol
Dimaano K, Castillo O Jr, Moazzez A, Ozao-Choy J, Dauphine C.
PMID: 41729467 [PubMed - as supplied by publisher]
Prognostic significance of circulating tumor DNA in early breast cancer: a systematic review and meta-analysis.
Breast Cancer Res Treat
Sisca L, Polito MG, Silletta M, La Cesa A, Scafetta R, Donato M, Gullotta CM, Guarino A, Barnini G, Speziale E, Troiano R, Foderaro S, Iuliani M, Simonetti S, Cavalieri S, Calagna S, Cortellini A, Vincenzi B, Tonini G, Pantano F.
PMID: 41729350 [PubMed - indexed for MEDLINE]
Impact of immune-related adverse events on response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer: a single-institution retrospective study.
Breast Cancer Res Treat
Sterpi M, Dreyfus N, Lo Y, Fineberg S, Gill H, Makower D.
PMID: 41729316 [PubMed - indexed for MEDLINE]
NAT10 Modulates Breast Cancer Progression Via Acā“C-Mediated Regulation of TRAF6 Expression and Glycolytic Metabolism.
Mol Carcinog
Bai W, Zhu M, Kan X, Zhang Y, Zhang Y.
PMID: 41728772 [PubMed - as supplied by publisher]
Systematic Review and Single-Arm Meta-Analysis of Bevacizumab Combined with Chemotherapy or Immunotherapy for Oncological Outcomes in Advanced/Recurrent Ovarian Clear Cell Carcinoma.
Cancer Invest
Gu Y, Tang Y, Zheng C, Wang Y.
PMID: 41728770 [PubMed - as supplied by publisher]
A pathology-based surrogate model for chemotherapy decision-making in intermediate-risk luminal breast cancer: validation of histologic grade and Ki67 in a Chinese population.
Front Med (Lausanne)
Li G, Zeng Y, Sun Y.
PMID: 41728598 [PubMed]
Epidemiological Landscape of Breast Cancer in Northern India: A Narrative Review of Jammu and Kashmir.
Cureus
Devi G, Rathod M, Kaliya M, Rathod A.
PMID: 41728440 [PubMed]
Epidemiological Profile, Clinical Characteristics, and Management of Ovarian Cancer in Eastern India: A Hospital-Based Study.
Cureus
Barik A, Singh V, Ghosh MD, Choudhary A, Yadav P.
PMID: 41728398 [PubMed]
A Remote Adapted Physical Activity Intervention for Women With Breast Cancer and Severe Depressive or Anxiety Symptoms: Series of N-of-1 Trials With Ecological Momentary Assessment.
Clin Psychol Eur
Caudroit J, St-Amour S, Lapointe J, Romain AJ, Comtois AS, Chevance G, Bernard P.
PMID: 41727814 [PubMed]
Global trends and disease burden of elderly male breast cancer, 1990-2021: a population-based study.
Front Endocrinol (Lausanne)
Liu S, Xu J, Zhang H, Tang Y, Han X, Xiong W, Fan L, Su C, Sui Z, Zhao W.
PMID: 41727696 [PubMed - indexed for MEDLINE]
BMI-stratified phenotypes of polycystic ovary syndrome: advances in gut microbiota research and personalized management strategies.
Front Endocrinol (Lausanne)
Su B, Cao Y, Ma L, Huang J.
PMID: 41727680 [PubMed - indexed for MEDLINE]
Machine learning model based on dual-layer detector spectral CT radiomics features for differentiating luminal and non-luminal breast cancer.
Front Oncol
Song Z, Ma Y, Dou Z, Shi B.
PMID: 41727670 [PubMed]
Overcoming immune resistance in ovarian cancer: checkpoint inhibitors, tumor microenvironment, and translational advances.
Front Oncol
Yue S, Wen T, Liu X, Tang J, Liu Y, Peng S.
PMID: 41727661 [PubMed]
Multi-colorized tint map for distinguishing triple-negative breast cancers from cysts and fibroadenomas based on the tumor margin.
Front Oncol
Xiang H, Chen X, Tan X, Chen X, Lv H, Sun D.
PMID: 41727649 [PubMed]
A machine learning approach to a nine-SNP immunogenetic score for prognostic stratification in cervical cancer.
Front Immunol
Zidi S, Yacoubi-Loueslati B, Ben Abdelmoumen Mardassi B, Almawi WY.
PMID: 41727446 [PubMed - indexed for MEDLINE]
Enhancing Breast Cancer Recurrence Prediction Across Treatment Scenarios with Weighted Cox Mixtures.
AMIA Annu Symp Proc
Haji HE, Tariq A, Souadka A, Sbihi N, Batalini F, Ghogho M, Banerjee I.
PMID: 41726459 [PubMed - indexed for MEDLINE]
Commentary: Evolution and hotspots in breast cancer organoid research: insights from a bibliometric and visual knowledge mapping study (2005-2024).
Front Oncol
Luo X, Zhang Z, Zhao H.
PMID: 41726367 [PubMed]
Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody-drug conjugate in breast cancer.
Oncol Rev
Sofianidi AA, Papatheodoridi A, Dimitrakakis C, Marinopoulos S, Michalaki V, Zagouri F.
PMID: 41726150 [PubMed]
Articles 1 - 20 / 324814
Page 1 of 16241
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy